Question to the Department for Business, Energy and Industrial Strategy:

To ask Her Majesty's Government whether they (1) intend to allocate, or (2) would consider allocating on the basis of scientific advice, further funding to UK Research and Innovation to support research on vaccine responses in groups of immune-supressed individuals.

The Department’s R&D settlement has increased to £11.1 billion for 2021/22. This includes an ambitious three year settlement for core research funding for National Academies and UK Research and Innovation’s (UKRI) core research budgets. In line with the Haldane Principles, UKRI will determine how funding will be allocated across research councils.